Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate

Introduction We present tri‐modality therapy with i‐125 brachytherapy for high‐risk prostate cancer after holmium laser enucleation of the prostate. Case presentation A 75‐year‐old man had visited our hospital with complaints of dysuria. Holmium laser enucleation of the prostate was performed for be...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Makoto Nakiri, Kosuke Ueda, Naoyuki Ogasawara, Hirofumi Kurose, Keiichiro Uemura, Kiyoaki Nishihara, Koichiro Muraki, Chikayuki Hattori, Etsuyo Ogo, Tsukasa Igawa
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2022-07-01
Rangatū:	IJU Case Reports
Ngā marau:	benign prostatic hyperplasia brachytherapy dysuria holmium prostate cancer
Urunga tuihono:	https://doi.org/10.1002/iju5.12437
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!